» Articles » PMID: 35163933

Recent Developments in Nitric Oxide Donors and Delivery for Antimicrobial and Anti-Biofilm Applications

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2022 Feb 15
PMID 35163933
Authors
Affiliations
Soon will be listed here.
Abstract

The use of nitric oxide (NO) is emerging as a promising, novel approach for the treatment of antibiotic resistant bacteria and biofilm infections. Depending on the concentration, NO can induce biofilm dispersal, increase bacteria susceptibility to antibiotic treatment, and induce cell damage or cell death via the formation of reactive oxygen or reactive nitrogen species. The use of NO is, however, limited by its reactivity, which can affect NO delivery to its target site and result in off-target effects. To overcome these issues, and enable spatial or temporal control over NO release, various strategies for the design of NO-releasing materials, including the incorporation of photo-activable, charge-switchable, or bacteria-targeting groups, have been developed. Other strategies have focused on increased NO storage and delivery by encapsulation or conjugation of NO donors within a single polymeric framework. This review compiles recent developments in NO drugs and NO-releasing materials designed for applications in antimicrobial or anti-biofilm treatment and discusses limitations and variability in biological responses in response to the use of NO for bacterial eradiation.

Citing Articles

Mimicking the Effects of Antimicrobial Blue Light: Exploring Single Stressors and Their Impact on Microbial Growth.

Kruszewska-Naczk B, Grinholc M, Rapacka-Zdonczyk A Antioxidants (Basel). 2025; 13(12.

PMID: 39765911 PMC: 11673782. DOI: 10.3390/antiox13121583.


Nanoparticle-Based Nitric Oxide Donors: Exploring Their Antimicrobial and Anti-Biofilm Capabilities.

Tortella Fuentes G, Fincheira P, Rubilar O, Leiva S, Fernandez I, Schoebitz M Antibiotics (Basel). 2024; 13(11).

PMID: 39596741 PMC: 11591520. DOI: 10.3390/antibiotics13111047.


Biofilm matrix: a multifaceted layer of biomolecules and a defensive barrier against antimicrobials.

Ragupathi H, Pushparaj M, Gopi S, Govindarajan D, Kandaswamy K Arch Microbiol. 2024; 206(11):432.

PMID: 39402397 DOI: 10.1007/s00203-024-04157-3.


Nitric oxide induces the distinct invisibility phenotype of Mycobacterium tuberculosis.

Gap-Gaupool B, Glenn S, Milburn E, Turapov O, Crosatti M, Hincks J Commun Biol. 2024; 7(1):1206.

PMID: 39342050 PMC: 11439070. DOI: 10.1038/s42003-024-06912-0.


Enhanced Nitric Oxide Delivery Through Self-Assembling Nanoparticles for Eradicating Gram-Negative Bacteria.

Lai X, Yu L, Huang X, Gardner W, Bamford S, Pigram P Adv Healthc Mater. 2024; 13(32):e2403046.

PMID: 39263842 PMC: 11670277. DOI: 10.1002/adhm.202403046.


References
1.
Sorba G, Medana C, Fruttero R, Cena C, Di Stilo A, Galli U . Water soluble furoxan derivatives as NO prodrugs. J Med Chem. 1997; 40(4):463-9. DOI: 10.1021/jm960379t. View

2.
Cariello A, Bispo P, Freitas Pereira de Souza G, Pignatari A, Ganzarolli de Oliveira M, Hofling-Lima A . Bactericidal effect of S-nitrosothiols against clinical isolates from keratitis. Clin Ophthalmol. 2012; 6:1907-14. PMC: 3508747. DOI: 10.2147/OPTH.S34830. View

3.
Yuan Z, Lin C, He Y, Tao B, Chen M, Zhang J . Near-Infrared Light-Triggered Nitric-Oxide-Enhanced Photodynamic Therapy and Low-Temperature Photothermal Therapy for Biofilm Elimination. ACS Nano. 2020; 14(3):3546-3562. DOI: 10.1021/acsnano.9b09871. View

4.
Backlund C, Worley B, Sergesketter A, Schoenfisch M . Kinetic-dependent Killing of Oral Pathogens with Nitric Oxide. J Dent Res. 2015; 94(8):1092-8. PMC: 4530389. DOI: 10.1177/0022034515589314. View

5.
Rong F, Tang Y, Wang T, Feng T, Song J, Li P . Nitric Oxide-Releasing Polymeric Materials for Antimicrobial Applications: A Review. Antioxidants (Basel). 2019; 8(11). PMC: 6912614. DOI: 10.3390/antiox8110556. View